	White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysis. Mol Psychiatry Barendse MEA, Poortman SR, Ching CRK, Cahn W, Cannon DM, Castro-Fornieles J, Delavari F, Fullerton JM, Hillegers M, McDonald C, Mitchell PB, Mueller BA, Pena M, Ozerdem A, Piguet C, Roberts G, Saccaro LF, Saricicek Aydogan A, de la Serna E, Sponheim SR, Sugranyes G, Xuan L, Zorlu N, Thompson PM, van Haren NEM. PMID: 42168580 [PubMed - as supplied by publisher]
	Inhibitory control deficits and ventral attention network alterations linked to apathy in schizophrenia. Transl Psychiatry Deng W, van Tol MJ, Marsman JC, Kos C, Servaas MN, Aleman A. PMID: 42168148 [PubMed - as supplied by publisher]
	Early-Onset Cannabis Use, Retinal Biomarkers, and Risk for Schizophrenia Preliminary Study. Clin Ther Valenti DA, Kailher H. PMID: 42167975 [PubMed - as supplied by publisher]
	Impact of pre-existing schizophrenia spectrum disorder on the receipt of surgery and other treatments for non-small cell lung cancer: A multicenter nationwide cohort study in Japan. Chest Yamada Y, Fujiwara M, Ishii T, Watanabe T, Fujimori M, Nakaya N, Kawamura T, Otsuki K, Ichihara E, Shimazu T, Hinotsu S, Uchitomi Y, Inagaki M. PMID: 42167588 [PubMed - as supplied by publisher]
	Estradiol Surges as Dual-Purpose Mechanisms in Evolutionary Psychiatry: Neuroendocrine Stabilization, Stress Regulation, and Psychosis Vulnerability. Neurosci Biobehav Rev Carlson J, Kulkarni J. PMID: 42167420 [PubMed - as supplied by publisher]
	Basic Sensory Risk Markers Characteristic of Schizophrenia in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. Neurosci Biobehav Rev Ragalmuto FGM, Oranje B, Ziermans T. PMID: 42167419 [PubMed - as supplied by publisher]
	Medication adherence, cannabis use, and depressive symptoms in first-episode psychosis: longitudinal study. J Ment Health Ricci V, Sarni A, Fraccalini T, Maina G. PMID: 42166351 [PubMed - as supplied by publisher]
	Prevalence, adherence, and health care resource utilization in schizophrenia: A national and state-level analysis of US Medicaid Beneficiaries. J Manag Care Spec Pharm Parks J, Xiang P, Patel R, McBride K, Costantino H, Mirza S, Borsos K. PMID: 42166304 [PubMed - indexed for MEDLINE]
	Hope-Enhancing Interventions in Schizophrenia Survivors: A Snyder's Hope Theory-Based Scoping Review. J Multidiscip Healthc Widianti E, Suryani S, Sunjaya DK, Iskandar S. PMID: 42164072 [PubMed]
	Managing auditory hallucination symptoms in patients with schizophrenia in China: a best practice implementation project. JBI Evid Implement Jin X, Shen T, Wang Y, Cai J, Dai Z, Li L, Shi Z, Huang C. PMID: 42163558 [PubMed - as supplied by publisher]
	Advances in schizophrenia research and treatment: exploring neurotransmitter imbalances, genetics, and innovative therapies. Prog Neuropsychopharmacol Biol Psychiatry , Fi, Hroudová J. PMID: 42162691 [PubMed - as supplied by publisher]
	Rethinking schizophrenia: insights from genomics and implications for research. Mol Psychiatry Owen MJ, O'Donovan MC. PMID: 42162224 [PubMed - as supplied by publisher]
	High Clozapine Serum Levels Do Not Improve Response: An Observational Study in Patients with Schizophrenia Treated with Clozapine in a Naturalistic Setting. Pharmacopsychiatry Hart XM, Hirjak D, Eap CB, Eichentopf L, Fritze S, Lense XM, Scharf D, Schilling C, Schwind N, Post P, Wesner K, Gründer G. PMID: 42161261 [PubMed - as supplied by publisher]
	Short-term development of neurocognition in early-stage schizophrenia with predominant negative symptoms. Psychiatry Res Yang Y, Zhu Y, Wu R, Jiang F, Cao D. PMID: 42161032 [PubMed - as supplied by publisher]
	A mixed methods study of program-level factors influencing patient and family engagement in first episode psychosis coordinated specialty care. Schizophr Res Foo CYS, Leonard CJ, McLaughlin MM, Johnson KA, Öngür D, Mueser KT, Cather C. PMID: 42160903 [PubMed - as supplied by publisher]
	Heat Shock Proteins in Schizophrenia: Integrating Stress Responses, Molecular Pathways, and Emerging Therapeutic Strategies. Neuroscientist Ebrahimi MN, Banazadeh M, Kohlmeier KA, Shabani M. PMID: 42159268 [PubMed - as supplied by publisher]
	Dual-pathway inhibitory dysfunction in schizophrenia: MEG and behavioral markers for risk stratification. J Psychiatry Neurosci Han Y, Du Y, Xia Y, Hua L, Yao Z, Lu Q. PMID: 42159174 [PubMed - indexed for MEDLINE]
	PSPH and CXCL2 Predict Treatment Response in First-Episode Schizophrenia: a Retrospective Study. Clin Lab Zheng J. PMID: 42159130 [PubMed - indexed for MEDLINE]
	Association of nitric oxide and neurotrophin-3 with cognitive dysfunction in schizophrenia spectrum disorders (SSD): A cross-sectional comparative study. Indian J Psychiatry Periasamy T, Murugiah V, Thankamoni RK, Alexander H, Gurusamy HM, Stanley RRB. PMID: 42158510 [PubMed]
	Stability-Driven Selection of EEG Connectivity Features for Psychosis Classification: A Network-Based Machine Learning Approach. CNS Neurosci Ther Naeim M, Narimani M. PMID: 42157703 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 68868

Page 1 of 3444



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy